Cargando…
Assessment of the Concentration of Endogenous Factors Regulating Angiogenesis, VASH-1 and VEGF-A, in the Blood Serum of Patients with Neuroendocrine Neoplasms
Neuroendocrine neoplasms (NENs) constitute about 2% of all malignant neoplasms, and the angiogenesis process in these tumors is still of a great interest. Vasohibin-1 (VASH-1) is an angiogenesis inhibitor, while vascular endothelial growth factor A (VEGF-A) is one of the main factors promoting vascu...
Autores principales: | Strzelczyk, Janusz, Wójcik-Giertuga, Monika, Cuber, Piotr, Biernacki, Krzysztof, Kos-Kudła, Beata, Strzelczyk, Joanna Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966743/ https://www.ncbi.nlm.nih.gov/pubmed/35372578 http://dx.doi.org/10.1155/2022/9084393 |
Ejemplares similares
-
Selected Parameters of Bone Turnover in Neuroendocrine Tumors—A Potential Clinical Use?
por: Strzelczyk, Janusz, et al.
Publicado: (2023) -
The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
por: Wójcik-Giertuga, Monika, et al.
Publicado: (2023) -
Does Thyroid Hormone Metabolism Correlate with the Objective Assessment of the Vestibular Organ in Patients with Vertigo?
por: Miśkiewicz-Orczyk, Katarzyna, et al.
Publicado: (2022) -
Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023) -
Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)